Cargando…

ARDS following oesophagectomy: a comparison of two trials

INTRODUCTION: The Beta Agonist Lung Injury Trial-Prevention (BALTI-P) translational substudy and Vitamin D to Prevent Acute Lung Injury Following Oesophagectomy (VINDALOO) trials recruited patients undergoing oesophagectomy, 4 years apart. The acute respiratory distress syndrome (ARDS) rates were lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howells, Phillip A, Aldridge, Kerrie A, Parekh, Dhruv, Park, Daniel, Tucker, Olga, Dancer, Rachel C A, Gao, Fang, Perkins, Gavin D, Thickett, David R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Critical Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687524/ https://www.ncbi.nlm.nih.gov/pubmed/29435341 http://dx.doi.org/10.1136/bmjresp-2017-000207

Ejemplares similares

Dysregulated alveolar function and complications in smokers following oesophagectomy
por: Lugg, Sebastian T., et al.
Publicado: (2019)

Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)
por: Dancer, Rachel C A, et al.
Publicado: (2015)

Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial
por: Parekh, Dhruv, et al.
Publicado: (2013)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
por: Mahida, Rahul Y, et al.
Publicado: (2020)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

Tidal changes on CT and progression of ARDS
por: Cereda, Maurizio, et al.
Publicado: (2017)

COMPARISON OF COVID-19 PATIENTS ADMITTED TO THE HOSPITAL WITH ARDS AND THOSE WHO PROGRESS TO IT DURING HOSPITALIZATION
por: IMRAN, MARYAM, et al.
Publicado: (2021)

OUTCOMES OF EXTRACORPOREAL MEMBRANE OXYGENATION IN ARDS DUE TO COVID-19: COMPARISON OF THE FIRST AND THE SECOND WAVE
por: REDDY, ROHIT, et al.
Publicado: (2021)

MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022)

EXTRA-CORPOREAL CARBON DIOXIDE REMOVAL IN COVID-19 ARDS
por: Boparai, Sukhmani, et al.
Publicado: (2020)

PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)

CHANGES IN ARDS MANAGEMENT AS A RESULT OF THE COVID-19 PANDEMIC
por: MACHURICK, MAXWELL, et al.
Publicado: (2021)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS
por: White, Kyle, et al.
Publicado: (2020)

ENDOTRACHEAL INTUBATION TIMING AND OUTCOME IN ARDS DUE TO COVID-19 INFECTION
por: PEREZ GUTIERREZ, VICTOR, et al.
Publicado: (2021)

ELEVATED D-DIMER PREDICTS DETERIORATION OF ARDS IN PATIENTS WITH COVID-19
por: LOPEZ RUIZ, ARNALDO, et al.
Publicado: (2021)

PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021)

PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA IN COVID-19 ARDS: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

The Effect of Alcohol Consumption on the Risk of ARDS: A Systematic Review and Meta-Analysis
por: Simou, Evangelia, et al.
Publicado: (2018)

A CASE OF PRIAPISM IN A MAN ADMITTED TO THE ICU FOR COVID-19 ARDS
por: ANDERSEN, KARL, et al.
Publicado: (2021)

COVID-19-RELATED ARDS PHENOTYPES AND PROGRESSION BETWEEN THEM: A CASE REPORT
por: Steff, Rodney, et al.
Publicado: (2020)

USE OF TISSUE PLASMINOGEN ACTIVATOR IN COVID-19 ARDS: A RETROSPECTIVE CASE SERIES
por: NEMEH, CHRISTOPHER, et al.
Publicado: (2021)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

DOES EXTRACORPOREAL MEMBRANE OXYGENATION SAVE LIVES IN COVID-19-ASSOCIATED SEVERE ARDS
por: VARGHESE, JOBIN, et al.
Publicado: (2021)

PROPOFOL-RELATED INFUSION SYNDROME IN A PATIENT WITH ARDS SECONDARY TO THE NOVEL COVID-19
por: FREEMAN, HOWARD, et al.
Publicado: (2021)

CORRELATION OF C-REACTIVE PROTEIN (CRP) WITH ICU COVID-19 ARDS MORTALITY IN ADULTS
por: CHANDRAN, RAVI T, et al.
Publicado: (2022)

Vitamin D to Prevent Lung Injury Following Esophagectomy—A Randomized, Placebo-Controlled Trial*
por: Parekh, Dhruv, et al.
Publicado: (2018)

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model
por: Cardenes, Nayra, et al.
Publicado: (2019)

Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study
por: Spadaro, Savino, et al.
Publicado: (2017)

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
por: Wadud, Nafisa, et al.
Publicado: (2020)

AIRWAY PRESSURE RELEASE VENTILATION USE IN COVID-19 ARDS: A SINGLE CENTER OBSERVATIONAL STUDY
por: PERINKULAM SATHYANARAYANAN, SWAMINATHAN, et al.
Publicado: (2021)

IMPROVING COMPLIANCE WITH CONTINUOUS ANTERIOR CHEST COMPRESSION IN ARDS CAUSED BY COVID-19: A CASE SERIES
por: PENG, JASON L, et al.
Publicado: (2022)

Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice
por: Lax, Sian, et al.
Publicado: (2017)

SHAKEN, NOT STIRRED: HIGH FREQUENCY PERCUSSIVE VENTILATION AS A SALVAGE THERAPY IN SEVERE ARDS DUE TO COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2021)

Clinical characteristics of patients with a risk of pulmonary artery hypertension secondary to ARDS in a high-altitude area
por: Zhu, Peng, et al.
Publicado: (2023)

OLD MEDICINE FOR NEW PROBLEMS: POTENTIAL ROLE OF A NOVEL TREATMENT USING NEBULIZED HEPARIN IN COVID-19 ARDS
por: DOUEN, AARON, et al.
Publicado: (2021)

NEUROMUSCULAR BLOCKING AGENT BUNDLES IN THE MEDICAL ICU TO PREVENT PROLONGED USE OF PARALYTICS IN PATIENTS WITH COVID-19-RELATED ARDS
por: PINCHOVER, ZACHARY S, et al.
Publicado: (2022)

CIRCULATING DAMAGE-ASSOCIATED MOLECULAR PATTERNS (DAMPS) AS PROGNOSTIC MARKERS OF DISEASE SEVERITY IN PATIENTS WITH COVID-19 ARDS IN THE ICU
por: ALGHANIM, FAHID, et al.
Publicado: (2022)

RADIOGRAPHIC AND CLINICAL CORRELATIONS IN SURVIVORS WITH POST-ARDS RELATED COVID-19: WHAT ARE RISK FACTORS FOR RESIDUAL PULMONARY ABNORMALITIES?
por: SADIGOV, ALIZAMIN SI
Publicado: (2022)

IMPACT OF VENTILATOR MODEL ON MORTALITY: A RETROSPECTIVE CROSS-SECTIONAL STUDY IN 147 MECHANICALLY VENTILATED PATIENTS WITH COVID-19 ARDS
por: Castaneda, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ql97r50d0f5imsksf0a6bl3o7r